The major current objectives of the Pathology Committee of the Cancer and Leukemia Group B (CALGB) include: 1) provision of quality control in the histopathologic diangosis of various noeplasms in order to insure proper patient accession into protocols, 2) correlation of histologic classes of noeplasms with the incidence and duration of remission and overall survival, 3) correlation of cytologic types of leukemias and lymphomas with immunologic, cytogeneic, and molecular biologic markers, 4) study of malignant mesotheliomas by means of morphologic, histochemical and ultrastructural methods in order to classify and distinguish these neoplasms from other cancers, 5) determination of whether the fraction of cells in the S-phase of the proliferative cycle (S%), as determined by flow cytometry or 3H-thymidine, bromodeoxyuridine (BUdR) and Ki-67 labelling indices, provide independent prognostic information in patients with breast cancer, and 6) identification of long-term survivors with small cell lung cancer by means of a monoclonal antibody reagent (SCCL 175) which was developed against small cell carcinoma cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA037055-07
Application #
3557958
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1984-04-01
Project End
1993-03-31
Budget Start
1990-04-05
Budget End
1991-03-31
Support Year
7
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Cooper, G S; Kamel, F; Sandler, D P et al. (1996) Risk of adult acute leukemia in relation to prior immune-related conditions. Cancer Epidemiol Biomarkers Prev 5:867-72
Stone, R M; Berg, D T; George, S L et al. (1995) Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. N Engl J Med 332:1671-7
Liu, E; Thor, A; He, M et al. (1992) The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene 7:1027-32
Davey, F R; Lawrence, D; MacCallum, J et al. (1992) Morphologic characteristics of acute lymphoblastic leukemia (ALL) with abnormalities of chromosome 8, band q24. Am J Hematol 40:183-91
Elghetany, M T; Sullivan, A K; Kurec, A S et al. (1992) The use of monoclonal antibodies against primary myeloid granules in normal and leukemic cells. Am J Clin Pathol 98:430-6
Ben-Ezra, J; Burke, J S; Swartz, W G et al. (1989) Small lymphocytic lymphoma: a clinicopathologic analysis of 268 cases. Blood 73:579-87
Davey, F R; Davis, R B; MacCallum, J M et al. (1989) Morphologic and cytochemical characteristics of acute promyelocytic leukemia. Am J Hematol 30:221-7